Skip to Content

Shandong Qilu King-Phar Pharmaceutical, China, 2024

GMP Audit Report

Company
Shandong Qilu King-Phar Pharmaceutical

Product(s)
Ivermectin

Country
China

Audit Year
2024

0.00 € 0.00 €
0.00 €